NaiBin Chen

Sun Yat-sen University — China

Medicine · Health Sciences

9h-index273citations25works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(17), Lung Cancer Treatments and Mutations(8), Radiomics and Machine Learning in Medical Imaging(8), Medical Imaging Techniques and Applications(5), Esophageal Cancer Research and Treatment(5)

Publications25 total

A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer
Cancer Medicine·2023· 1 citedOpen Access
Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (<scp>GASTO</scp> 1059)
Cancer Medicine·2023· 6 citedOpen Access
Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients
European Journal of Nuclear Medicine and Molecular Imaging·2023· 20 cited
Value of Patlak-Ki from ultra-high sensitivity dynamic total body [<sup>18</sup>F]FDG PET/CT for evaluation of treatment response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer (LA-NSCLC) patients.
Journal of Clinical Oncology·2023
Respiratory toxicities after concurrent chemoradiotherapy and subsequent consolidation immune checkpoint inhibitors in locally advanced non-small cell lung cancer: Infectious and non-infectious subtypes by pathogen NGS testing.
Journal of Clinical Oncology·2023· 1 cited
Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)
International Journal of Radiation Oncology*Biology*Physics·2023· 16 cited
Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
Frontiers in Oncology·2022· 5 citedOpen Access
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment
Radiation Oncology·2022· 37 citedOpen Access
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
Frontiers in Oncology·2022· 1 citedOpen Access
Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)
International Journal of Radiation Oncology*Biology*Physics·2022· 21 cited
Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes
European Journal of Nuclear Medicine and Molecular Imaging·2022· 39 cited
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy
Radiotherapy and Oncology·2022· 9 cited
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model
Radiotherapy and Oncology·2021· 8 cited
A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly
Frontiers in Oncology·2021· 2 citedOpen Access
Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase II Prospective Clinical Trial (GASTO1011)
Practical Radiation Oncology·2021· 38 cited
Assessing tumor metabolic heterogeneity of non-small cell lung cancer with total body PET-CT imaging on the uExplorer: Analysis of dynamic changes of 18F-FDG uptake.
Journal of Clinical Oncology·2021
Dynamic 18F-FDG Total body PET Imaging as a predictive marker of induction chemo-immunotherapy response in locally advanced non-small cell lung cancer.
Journal of Clinical Oncology·2021· 1 cited
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)
Lung Cancer·2021· 6 citedOpen Access
Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
Current Oncology·2021· 7 citedOpen Access
Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
Radiation Oncology·2020· 11 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Bo Qiu(24), JinYu Guo(21), Hui Liu(19), Daquan Wang(16), FangJie Liu(16), Qiwen Li(15), XinLei Ai(11), Suping Guo(9), Rui Zhou(8), Chu Chu(8), Yin Zhou(7), Mai Xiong(6), Yingjia Wu(6), Yifeng Luo(5), Xiaoyan Huang(5), Nan Hu(5), Jibin Li(5), Songran Liu(4), Wei Fan(4), Bin Wang(4)